Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 14, 812 - 813 (2008)
doi:10.1038/nm0808-812
Predicting the future for people with lung cancer
- Yang Xie and John D. Minna are in the Department of Clinical Sciences and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, Texas 75390-8593, USA.
e-mail: yang.xie@utsouthwestern.edu
e-mail: john.minna@utsouthwestern.edu
Abstract
A large multicenter study shows that lung adenocarcinomas have messenger RNA expression signatures that greatly add to the use of clinical data in predicting an individual's survival (pages 822–827).
A major goal of 'personalized' medicine for cancer is to develop the tools to sample a patient's tumor and then perform molecular analyses to identify the tumor type, its behavior in the patient, the patient's prognosis and the best treatment. The study by Shedden et al.1 in this issue of Nature Medicine provides an important step in this direction.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Behavioral Responses of Epidermal Langerhans Cells In Situ to Local Pathological StimuliJournal of Investigative Dermatology Original Article
